Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Lupin Australia Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (288)
ARTG (239)
Prescription medicine registration (18)

Date

2024 (48)
2023 (47)
2022 (222)
2021 (8)
2020 (33)
2019 (21)
2018 (32)
2017 (11)
2016 (10)
2014 (27)
2013 (17)
2012 (2)
2011 (16)
2010 (19)
2009 (1)
2008 (21)
2007 (5)
2001 (1)
1991 (4)

Results for "[search-keyword]"

Search

Sponsor content

545 result(s) found, displaying 341 to 350

PHENTERMINE LAPL phentermine 40 mg sustained release capsule blister pack (304020)

4 May 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTERMINE LAPL phentermine 40 mg sustained release capsule blister pack.
PHENTERMINE LAPL phentermine 30 mg sustained release capsule blister pack (304021)

4 May 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTERMINE LAPL phentermine 30 mg sustained release capsule blister pack.
PHENTERMINE GH phentermine 30 mg sustained release capsule blister pack (304022)

4 May 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTERMINE GH phentermine 30 mg sustained release capsule blister pack.
PHENTERMINE LAPL phentermine 15 mg sustained release capsule blister pack (304023)

4 May 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTERMINE LAPL phentermine 15 mg sustained release capsule blister pack.
PHENTERMINE GH phentermine 40 mg sustained release capsule blister pack (304024)

4 May 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTERMINE GH phentermine 40 mg sustained release capsule blister pack.
ESOMEPRAZOLE GENERICHEALTH esomeprazole (as magnesium) 20 mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2021

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
ESOMEPRAZOLE GENERICHEALTH esomeprazole (as magnesium) 40 mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2021

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
Irbesartan HCT GH 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2021

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
Irbesartan HCT GH 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2021

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
Irbesartan HCT GH 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2021

Cancellation by sponsor

Requested by Lupin Australia Pty Limited

Pages

First page
Previous page
…
Page 31
Page 32
Page 33
Page 34
Current page 35
Page 36
Page 37
Page 38
Page 39
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.